Human soluble CD39 displays substrate inhibition in a substrate-specific manner

CD39 (ectonucleoside triphosphate diphosphohydrolase-1; ENTPD1) metabolizes extracellular ATP and ADP to AMP. AMP is subsequently metabolized by CD79 to adenosine. CD39 activity is therefore a key regulator of purinergic signalling in cancer, thrombosis, and autoimmune diseases. In this study we dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Vadlamani, Venkat M. K., Gunasinghe, Kavinda K. J., Chee, Xavier W., Rahman, Taufiq, Harper, Matthew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238538/
https://www.ncbi.nlm.nih.gov/pubmed/37268726
http://dx.doi.org/10.1038/s41598-023-36257-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238538/
https://www.ncbi.nlm.nih.gov/pubmed/37268726
http://dx.doi.org/10.1038/s41598-023-36257-3

Ejemplares similares